$XGN

Exagen Inc

  • NASDAQ
  • Health Services
  • Medical/Nursing Services
  • Manufacturing
  • Dental Laboratories

PRICE

$4.645 ▲0.541%

Delayed Price

VOLUME

3,216

DAY RANGE

-

52 WEEK

4.15 - 17.58

Join Discuss about XGN with like-minded investors

profile
@dros #droscrew
recently

Positive Initiations 11/10: $A $ABBV $ALGS $ASAN $BLFS $BLI $BMRA $BRKS $CDMO $CSTL $CYRX $DHR $EAR $HBIO $OCX $PLAN $PRAX $RGEN $SYRS $TARS $VRM $WK $WST $XGN

132 Replies 6 👍 13 🔥

Key Metrics

Market Cap

75.10 M

Beta

1.10

Avg. Volume

59.58 K

Shares Outstanding

16.26 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-08

Next Dividend Date

Company Information

Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE brand, several of which are based on the proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. Exagen's goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including rheumatoid arthritis and lupus.

CEO: Fortunato Rocca

Website:

HQ: 1261 Liberty Way Ste C Vista, 92081-8356 California

Related News